212Pb-VMT-a-peptide

N/A

Report date: 2025/11/19 17:58:19

NME

Base Information

Drug Name212Pb-VMT-a-peptide

Drug Alias Name[212Pb]VMT-α-peptide

ClassificationRadiation-emitting products > Nuclides > Lead > 212PbRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionSomatostatin receptor modulators

TargetsSomatostatin receptor

Therapy Area/IndicationsNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBJ Madan & co

China Registration ClassN/A

Develop Information

Active CompaniesBJ Madan & co

Inactive CompaniesN/A

Active IndicationsNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A